BSE Live
Apr 20, 16:01Prev. Close
942.55
Open Price
949.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 20, 15:55Prev. Close
943.95
Open Price
945.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
936.50 (138)
| Cash Flow of Zydus Lifesciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 7,444.70 | 4,239.80 | 2,032.20 | 1,163.90 | 1,688.50 | |
| Net CashFlow From Operating Activities | 3,114.00 | 1,999.10 | 1,078.20 | 1,310.70 | 2,225.30 | |
| Net Cash Used In Investing Activities | -4,503.60 | -1,830.60 | -1,959.70 | 768.20 | -2,713.80 | |
| Net Cash Used From Financing Activities | 1,384.50 | -300.80 | 827.00 | -1,709.80 | 257.20 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -5.10 | -132.30 | -54.50 | 369.10 | -231.30 | |
| Cash And Cash Equivalents Begin of Year | 108.10 | 240.40 | 302.60 | 154.00 | 385.30 | |
| Cash And Cash Equivalents End Of Year | 103.00 | 108.10 | 248.10 | 523.10 | 154.00 |
18.03.2026
Zydus, Torrent Pharma join hands to co-market Semaglutide injection
17.03.2026
26.02.2026
20.02.2026
10.02.2026
Zydus Life Standalone December 2025 Net Sales at Rs 2,283.60 crore, down 9.23% Y-o-Y
10.02.2026
Zydus Life Consolidated December 2025 Net Sales at Rs 6,864.50 crore, up 30.28% Y-o-Y
12.11.2025
Zydus Life Standalone September 2025 Net Sales at Rs 2,871.20 crore, up 9.56% Y-o-Y
07.11.2025
Zydus Life Consolidated September 2025 Net Sales at Rs 6,123.20 crore, up 16.92% Y-o-Y
12.07.2023
Zydus Lifescience Q1 PAT seen up 58.6% YoY to Rs 839.1 cr: Nirmal Bang
08.07.2022
Zydus Lifesciences Q1 PAT may dip 10.6% YoY to Rs 505.2 cr: Prabhudas Lilladher
13.01.2022
Cadila Healthcare Q3 PAT seen up 3.2% YoY to Rs 544 cr: Prabhudas Lilladher
06.10.2021
Cadila Healthcare Q2 PAT seen up 19% YoY to Rs 563.3 cr: Prabhudas Lilladher